[Skip to Content]
[Skip to Content Landing]
Other Articles
January 1940


Author Affiliations

Clinical Professor of Medicine, New York University College of Medicine; Visiting Physician, Harlem Hospital; Director of Pediatrics, Harlem Hospital NEW YORK
From the Littauer Pneumonia Research Fund, and the Medical Pediatric Services of Harlem Hospital.; These studies received financial support from the Metropolitan Life Insurance Company and from Mr. Bernard M. Baruch, Mr. Bernard M. Baruch Jr., Miss Belle N. Baruch and Mrs. H. Robert Samstag. The Altman Foundation contributed money for the preparation of the first serum used.

Am J Dis Child. 1940;59(1):84-93. doi:10.1001/archpedi.1940.01990120086008

Physicians who have seen prompt termination of pneumonia and reduction in deaths and complications induced by adequate doses of specific antipneumococcus serum are impressed by the value of this method of treatment. However, acceptance of this therapy for children has been slow because of alleged dangers and difficulties and because the mortality of the pneumonias is considerably less among children than among adults. Because of this skepticism, the alternation of specific serum therapy among children was continued at Harlem Hospital until statistical evidence of its value was available in an adequate series of cases. After the frequency of type XIV pneumonia in children was learned, therapeutic serum was prepared in horses by the Department of Health of New York city. The observations recorded here, which bring up to date observations previously reported elsewhere, have extended over ten years.

Therapeutic serum was administered when available, to alternate patients, even though the

First Page Preview View Large
First page PDF preview
First page PDF preview